NervGen Pharma Publishes Restated Annual Financial Report

• NervGen Pharma published restated consolidated financial statements for the fiscal years ended December 31, 2025 and 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NervGen Pharma Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-116627), on October 16, 2026, and is solely responsible for the information contained therein.